The Goldman Sachs Group Trims Stem (NYSE:STEM) Target Price to $2.00

Stem (NYSE:STEMFree Report) had its target price decreased by The Goldman Sachs Group from $2.50 to $2.00 in a research report report published on Monday morning, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock.

STEM has been the topic of a number of other research reports. Piper Sandler reduced their target price on Stem from $3.00 to $2.00 and set a neutral rating on the stock in a report on Thursday, April 11th. Evercore ISI dropped their price target on Stem from $13.00 to $9.00 and set an outperform rating for the company in a research note on Friday. BMO Capital Markets dropped their price target on Stem from $2.50 to $1.85 and set a market perform rating for the company in a research note on Friday. TD Cowen dropped their price target on Stem from $7.00 to $5.00 and set an outperform rating for the company in a research note on Thursday, February 29th. Finally, Susquehanna dropped their price target on Stem from $5.50 to $4.00 and set a positive rating for the company in a research note on Thursday, February 29th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of Hold and an average target price of $5.20.

Get Our Latest Analysis on Stem

Stem Trading Up 2.6 %

Shares of STEM stock opened at $1.40 on Monday. The stock’s fifty day moving average price is $1.98 and its two-hundred day moving average price is $2.82. The company has a market cap of $220.09 million, a PE ratio of -0.96 and a beta of 1.91. Stem has a fifty-two week low of $1.36 and a fifty-two week high of $7.79. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.78 and a current ratio of 1.88.

Stem (NYSE:STEMGet Free Report) last issued its earnings results on Thursday, May 2nd. The company reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.25). The business had revenue of $25.50 million during the quarter, compared to analyst estimates of $66.67 million. Stem had a negative net margin of 40.03% and a negative return on equity of 34.37%. The company’s revenue for the quarter was down 61.9% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.29) EPS. Equities analysts predict that Stem will post -0.51 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director David S. Buzby bought 33,800 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was acquired at an average cost of $1.81 per share, with a total value of $61,178.00. Following the transaction, the director now directly owns 768,448 shares in the company, valued at $1,390,890.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CRO Alan Russo sold 14,390 shares of Stem stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $3.17, for a total value of $45,616.30. Following the completion of the transaction, the executive now directly owns 158,204 shares of the company’s stock, valued at approximately $501,506.68. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director David S. Buzby bought 33,800 shares of Stem stock in a transaction dated Monday, March 18th. The stock was purchased at an average price of $1.81 per share, with a total value of $61,178.00. Following the completion of the purchase, the director now owns 768,448 shares in the company, valued at $1,390,890.88. The disclosure for this purchase can be found here. In the last three months, insiders purchased 130,418 shares of company stock valued at $238,045 and sold 772,268 shares valued at $1,650,229. 10.17% of the stock is owned by corporate insiders.

Institutional Trading of Stem

Several large investors have recently made changes to their positions in STEM. Bank of New York Mellon Corp grew its stake in shares of Stem by 7.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 646,918 shares of the company’s stock valued at $2,743,000 after buying an additional 43,859 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Stem by 16.3% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 35,187 shares of the company’s stock valued at $149,000 after buying an additional 4,924 shares during the period. SCP Investment LP grew its stake in shares of Stem by 303.9% in the 3rd quarter. SCP Investment LP now owns 164,800 shares of the company’s stock valued at $699,000 after buying an additional 124,000 shares during the period. Olympiad Research LP acquired a new stake in shares of Stem in the 3rd quarter valued at about $305,000. Finally, Principal Financial Group Inc. grew its stake in shares of Stem by 39.3% in the 3rd quarter. Principal Financial Group Inc. now owns 21,067 shares of the company’s stock valued at $89,000 after buying an additional 5,941 shares during the period. 61.63% of the stock is currently owned by institutional investors and hedge funds.

Stem Company Profile

(Get Free Report)

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

See Also

Analyst Recommendations for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.